16-346264-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003502.4(AXIN1):​c.762T>C​(p.Asp254Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.65 in 1,613,910 control chromosomes in the GnomAD database, including 346,703 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 36887 hom., cov: 33)
Exomes 𝑓: 0.65 ( 309816 hom. )

Consequence

AXIN1
NM_003502.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.19

Publications

51 publications found
Variant links:
Genes affected
AXIN1 (HGNC:903): (axin 1) This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain. The encoded protein interacts with adenomatosis polyposis coli, catenin beta-1, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. This protein functions as a negative regulator of the wingless-type MMTV integration site family, member 1 (WNT) signaling pathway and can induce apoptosis. The crystal structure of a portion of this protein, alone and in a complex with other proteins, has been resolved. Mutations in this gene have been associated with hepatocellular carcinoma, hepatoblastomas, ovarian endometriod adenocarcinomas, and medullablastomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
AXIN1 Gene-Disease associations (from GenCC):
  • caudal duplication
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 16-346264-A-G is Benign according to our data. Variant chr16-346264-A-G is described in ClinVar as Benign. ClinVar VariationId is 402405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.853 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003502.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN1
NM_003502.4
MANE Select
c.762T>Cp.Asp254Asp
synonymous
Exon 2 of 11NP_003493.1
AXIN1
NM_181050.3
c.762T>Cp.Asp254Asp
synonymous
Exon 2 of 10NP_851393.1
AXIN1
NR_134879.2
n.1198T>C
non_coding_transcript_exon
Exon 2 of 9

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN1
ENST00000262320.8
TSL:1 MANE Select
c.762T>Cp.Asp254Asp
synonymous
Exon 2 of 11ENSP00000262320.3
AXIN1
ENST00000354866.7
TSL:1
c.762T>Cp.Asp254Asp
synonymous
Exon 2 of 10ENSP00000346935.3
AXIN1
ENST00000461023.5
TSL:2
n.59T>C
non_coding_transcript_exon
Exon 1 of 8

Frequencies

GnomAD3 genomes
AF:
0.683
AC:
103838
AN:
151952
Hom.:
36834
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.861
Gnomad AMI
AF:
0.732
Gnomad AMR
AF:
0.564
Gnomad ASJ
AF:
0.506
Gnomad EAS
AF:
0.312
Gnomad SAS
AF:
0.746
Gnomad FIN
AF:
0.613
Gnomad MID
AF:
0.560
Gnomad NFE
AF:
0.648
Gnomad OTH
AF:
0.621
GnomAD2 exomes
AF:
0.607
AC:
152675
AN:
251444
AF XY:
0.618
show subpopulations
Gnomad AFR exome
AF:
0.874
Gnomad AMR exome
AF:
0.441
Gnomad ASJ exome
AF:
0.511
Gnomad EAS exome
AF:
0.299
Gnomad FIN exome
AF:
0.607
Gnomad NFE exome
AF:
0.643
Gnomad OTH exome
AF:
0.603
GnomAD4 exome
AF:
0.646
AC:
944285
AN:
1461840
Hom.:
309816
Cov.:
80
AF XY:
0.649
AC XY:
471621
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.873
AC:
29233
AN:
33480
American (AMR)
AF:
0.455
AC:
20347
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.513
AC:
13402
AN:
26136
East Asian (EAS)
AF:
0.343
AC:
13625
AN:
39700
South Asian (SAS)
AF:
0.739
AC:
63737
AN:
86258
European-Finnish (FIN)
AF:
0.609
AC:
32510
AN:
53374
Middle Eastern (MID)
AF:
0.559
AC:
3226
AN:
5768
European-Non Finnish (NFE)
AF:
0.657
AC:
730069
AN:
1112004
Other (OTH)
AF:
0.631
AC:
38136
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
22462
44925
67387
89850
112312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19076
38152
57228
76304
95380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.684
AC:
103951
AN:
152070
Hom.:
36887
Cov.:
33
AF XY:
0.680
AC XY:
50537
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.861
AC:
35746
AN:
41530
American (AMR)
AF:
0.564
AC:
8608
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.506
AC:
1758
AN:
3472
East Asian (EAS)
AF:
0.312
AC:
1605
AN:
5144
South Asian (SAS)
AF:
0.747
AC:
3590
AN:
4808
European-Finnish (FIN)
AF:
0.613
AC:
6473
AN:
10560
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.648
AC:
44024
AN:
67970
Other (OTH)
AF:
0.624
AC:
1316
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1583
3166
4749
6332
7915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.652
Hom.:
89853
Bravo
AF:
0.677
Asia WGS
AF:
0.592
AC:
2055
AN:
3478
EpiCase
AF:
0.627
EpiControl
AF:
0.627

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.043
DANN
Benign
0.24
PhyloP100
-2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805105; hg19: chr16-396264; COSMIC: COSV51987760; API